ProSciento, Inc.

Exhibiton
No items found.
No items found.

ProSciento is a leading specialty clinical research organization (CRO) exclusively focused on NASH, diabetes, obesity and related metabolic diseases. Building on 15 years of experience and more than 280 metabolic clinical projects conducted, ProSciento provides customized clinical research services for multinational, early development clinical trial programs designed to give our clients an advantage in today’s rapidly evolving landscape of metabolic drug and device development.